Hints and tips:
...Bayer: Shares in the German chemicals and pharma company gained 2 per cent after reports it may spin off its CropScience unit....
...In Bayer’s case, its CropScience division, which provides seeds and weedkillers to farmers, feared in 2016 that it could be marginalised as a massive consolidation wave swept through the sector....
...The German champions beat Union Berlin 1-0 to close the gap on table toppers Bayer Leverkusen to four points. But none of that, frankly matters....
...Claims escalation caught out Bayer and BP in their respective litigation battles. Worrisomely, the FDA says complaints have accelerated since May, with 168 deaths blamed on these devices....
...Scott Bardo, an analyst at Berenberg, said the issue was “unlikely to descend into the next Bayer Monsanto”, referring to a settlement of up to $10.9bn over the potential carcinogenic effects of the German...
...“[Investors] have been fairly traumatised by the Bayer Monsanto situation and the Johnson & Johnson talc litigation,” said Bernstein analyst Lisa Clive, referring to two recent multibillion-dollar payouts...
...Bayer, the German pharmaceutical group, also said it would donate 3m of its malaria tablets, but as they are not approved in the US, they need an emergency authorisation from the FDA....
...● Bayer jumped on hopes that a US court would slash the $289m of damages awarded by a jury over health effects of its Roundup weedkiller....
...The world’s biggest shipping container company AP Moller-Maersk is offloading its energy businesses to concentrate on transport and logistics, while German pharmaceuticals and chemicals group Bayer spun...
...The WannaCry ransomware outbreak infected medical devices, disabling radiology equipment made by Bayer....
...But while ChemChina pledged to support Syngenta’s existing operations, in a recognition of the political sensitivities surrounding the deal, by contrast Dow and Bayer have sought to persuade investors of...
...On the basis of peers such as Clariant and Lanxess (itself a spin-off from Bayer in 2005), Akzo Nobel’s specialty chemicals division might attract an enterprise value of about €7.5bn....
...However ebitda at its agricultural arm CropScience, which sells products such as insecticides and herbicides as well as seeds, fell 9.5 per cent year-on-year to €334m....
...In Bayer’s case, the shift to life sciences started as long ago as 2001, when the group paid €7.25bn for Aventis CropScience in what was then its largest acquisition....
...Panasonic Healthcare of Japan is working on similar services after its €1bn acquisition of a diabetes monitoring business from Bayer of Germany in June....
...Julian Little of Bayer CropScience disagreed....
...The cost to the planet of existing materials, such as plastics, simply isn’t counted, which makes sustainability quite a difficult path to take,” says Eben Bayer, a co-founder....
Record level of M&A activity is being driven by cheap capital and a race to develop new treatments
...Bayer of Germany in May paid $14bn for the over-the-counter business of Merck & Co of the US, while a month earlier Novartis agreed to form a consumer healthcare joint venture with GlaxoSmithKline....
...Qumu handled the task so smoothly that Bayer has since adopted it for all its videos....
...Companies like Bayer Cropsciences, Kaveri Seeds and Pesticides India are well placed to benefit from this trend. Saurabh Mukherjea is CEO of institutional equities, Ambit Capital....
...CropScience Syed Manzur Elahi, Chairman, Apex Adelchi Footwear Eduardo Eurnekian, CEO, Corporación América Douglas Flint, Group Chairman, HSBC Holdings Antonio Estrany y Gendre, President, Axion Energy...
...Germany’s Bayer CropScience said the move would reduce food quality and make European agriculture less competitive....
...Marijn Dekkers, chief executive, said: “The upward trend in our life science businesses – healthcare and cropscience – continued in the third quarter of 2012 …We remain on a successful path, and we confirm...
...Analysts at Barclays cut their rating on Bayer from “equal weight” to “underweight”, sending the German drugmaker’s shares falling 2.8 per cent to €73.57....
International Edition